Abstract:BACKGROUND:The nature and the mechanism involved in the formation of the multinucleated giant cells (MGCs) in various giant cell-containing lesions of the jaws are not fully understood. The aim of this study is to clarify the osteoclastic features of the MGCs in central giant cell granuloma (CGCG), peripheral giant cell granuloma (PGCG), cherubism, and aneurysmal bone cyst (ABC), and the mechanism underlying the interrelations between cellular components in the formation of the MGCs.METHODS:Immunohistochemical study with a panel of antibodies including vacuolar H+-ATPase (V-ATPase), carbonic anhydrase II (CA II), Cathepsin K, matrix metalloproteinases-9 (MMP-9), CD68, and proliferating cell nuclear antigen (PCNA), and enzyme histochemical staining for tartarate-resistant acid phosphatase (TRAP) were applied on a total number of 53 cases of giant cell-containing lesions including CGCG (n = 34), PGCG (n = 6), cherubism (n = 7), and ABC (n = 6). In situ hybridization was also carried out to detect the mRNA expression of the receptor activator of NF-kappaB ligand (RANKL), a newly identified cytokine that is shown to be essential in the osteoclastogenesis, its receptor RANK (receptor activator of NF-kappaB ligand), and its decoy receptor OPG (osteoprotegerin) in these four types of lesions.RESULTS:Immunohistochemical and enzyme histochemical studies showed that both the MGCs and a fraction of mononuclear cells in these lesions were strongly positive for TRAP, V-ATPase, CA II, Cathepsin K, MMP-9, and CD68, while the spindle-shaped mononuclear cells were positive for PCNA. The results with in situ hybridization indicated that RANKL mRNA was mainly expressed in the spindle mononuclear cells while OPG was extensively distributed in both the MGCs and the mononuclear cells. RANK mRNA was expressed in the MGCs and some round mononuclear cells.CONCLUSIONS:These results suggest that MGCs in the four types of giant cell-containing lesions of the jaws show characteristics of the osteoclast phenotype. The mononuclear stromal cells, which show TRAP positively, may be the precursors of the MGCs. RANKL, OPG, and RANK expressed in these lesions may play important roles in the formation of the MGCs. The similar characteristics and mechanisms in the differentiation of MGCs in these lesions also suggest that there might be a similar kind of pathogenesis involved in the formation of the MGCs in these lesions

[Expression of Receptor Activator of NF-kappa B Ligand and Osteoprotegerin Protein in the Giant Cell Lesions of Jaw].

The expression of BMP-2 in cementifying fibroma of the jaw and its clinical significance

[Expression of Macrophage Inflammatory Protein-1Alpha, a Disintegrin-Like and Metalloproteinase 8 and 12, and CD68 Protein in Giant Cell Lesions of Jaw and Giant Cell Tumors of Long Bone].

Expression of BMP-2 in Osteosarcoma of the Jaw Bone and Its Clinical Significance

The Expression of BMP-2mRNA in Osteosarcoma of the Jaw and Its Relationship to Lymph Node Metastasis

[Expression of a Disintegrin-Like and Metalloproteinase Protein 8 and 12 in the Giant Cell Lesions of Jaw].

Multinucleated Giant Cells in Various Forms of Giant Cell Containing Lesions of the Jaws Express Features of Osteoclasts.

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Study on the Mechanism of RANKL in Bone Absorption of Periapical Lesion

Gene Expression of Osteoprotegerin and Osteoclast Differentiation Factor in Giant Cell Tumor

Effect of Cytokines on in Vitro Bone Resorption by Cells Isolated from Giant Cell Tumor of Bone.

Nature of multinucleated giant cells in giant cell tumor and giant cell granuloma of the jaws

Evaluation Of Cd4, Cd8 And Programmed Death Ligand-1 Expression In Giant Cell Lesions Of The Jaw.

Expression And Localization Of Extracellular Matrix Metalloproteinase Inducer In Giant Cell Tumor Of Bone

Serglycin Induces Osteoclastogenesis and Promotes Tumor Growth in Giant Cell Tumor of Bone.

Expression of RANKL and OPG mRNA in apical periodontitis

Gene Expression of Glucocorticoid Receptor Alpha and Beta in Giant Cell Tumour of Bone: Evidence of Glucocorticoid-Stimulated Osteoclastogenesis by Stromal-Like Tumour Cells

[Central Giant Cell Lesions of the Jaws: a Clinicopathological Study of 31 Cases].

Expression and Significance of Receptor Activator of Nuclear Kb Ligand in Odontogenic Keratocyst

Differential Expression of Chemokines, Chemokine Receptors and Proteinases by Foreign Body Giant Cells (FBGCs) and Osteoclasts

Osteoclastic Bone Destruction and Its Regulating Factors in Oral Squamous Cell Carcinoma